Clinical Trials
37 trialsA Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
M.D. Anderson Cancer Center
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Mayo Clinic
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
Virginia Commonwealth University
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery
Roswell Park Cancer Institute
SMILE
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
ASPIRE
Wake Forest University Health Sciences
Study of Aspirin in Patients With Vestibular Schwannoma
Massachusetts Eye and Ear Infirmary
IMpALA
The Christie NHS Foundation Trust
Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer
Instituto de Investigación Sanitaria Aragón
ResToP
Fundacion CRIS de Investigación para Vencer el Cáncer
REPROGRAM-01
Centre Hospitalier Universitaire de Besancon
A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression
Peter MacCallum Cancer Centre, Australia
Low-PV
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
AIRPORT-MPN
Ottawa Hospital Research Institute
ASAP
German Cancer Research Center
Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Trial of Aspirin and Arginine Restriction in Colorectal Cancer
University of California, Irvine
PRIMA
Rutgers, The State University of New Jersey
Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma
University of California, San Francisco
The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study
University of Calgary
Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma
University of Utah
Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma
University of Utah
Breast 51
University of Virginia
PRIMMO
University Hospital, Ghent
Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Peking Union Medical College Hospital
IMpALA
The Christie NHS Foundation Trust
Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients
Sun Yat-sen University
A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients
Washington University School of Medicine
Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)
Icahn School of Medicine at Mount Sinai
ASPIDIA
Centre Francois Baclesse
ACABC
Zhejiang Provincial People's Hospital
ISCLAP
Icahn School of Medicine at Mount Sinai
Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy
Duke University
Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer
M.D. Anderson Cancer Center
Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma
M.D. Anderson Cancer Center